{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:20Z","timestamp":1786985180121,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515110458"],"award-info":[{"award-number":["2019A1515110458"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10731101-002"],"award-info":[{"award-number":["2018ZX10731101-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["20190804095916056"],"award-info":[{"award-number":["20190804095916056"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109142601702"],"award-info":[{"award-number":["JCYJ20200109142601702"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JSGG20200225152008136"],"award-info":[{"award-number":["JSGG20200225152008136"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130150ZX"],"award-info":[{"award-number":["2020T130150ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22037005"],"award-info":[{"award-number":["22037005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971927"],"award-info":[{"award-number":["81971927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biomaterials.2021.121062","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:26:40Z","timestamp":1628584000000},"page":"121062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-6861","authenticated-orcid":false,"given":"Fengling","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10255","key":"10.1016\/j.biomaterials.2021.121062_bib1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"issue":"10249","key":"10.1016\/j.biomaterials.2021.121062_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"issue":"10069","key":"10.1016\/j.biomaterials.2021.121062_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"issue":"10143","key":"10.1016\/j.biomaterials.2021.121062_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121062_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121062_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/infdis\/jiy187","article-title":"Immunization with a novel human type 5 adenovirus-vectored vaccine expressing the premembrane and envelope proteins of Zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models","volume":"218","author":"Guo","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121062_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.gt.3302347","article-title":"Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice","volume":"12","author":"Varnavski","year":"2005","journal-title":"Gene Ther."},{"issue":"22","key":"10.1016\/j.biomaterials.2021.121062_bib8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/adma.201503740","article-title":"Vaccine engineering with dual-functional mineral shell: a promising strategy to overcome preexisting immunity","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.biomaterials.2021.121062_bib10","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00783-12","article-title":"Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques","volume":"86","author":"Sun","year":"2012","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.biomaterials.2021.121062_bib11","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.vaccine.2011.03.042","article-title":"Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/mi.2011.45","article-title":"Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge","volume":"5","author":"Bolton","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib13","doi-asserted-by":"crossref","DOI":"10.15761\/GVI.1000128","article-title":"Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses","volume":"3","author":"Matchett","year":"2018","journal-title":"Glob Vaccines Immunol"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib14","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/s41467-020-18077-5","article-title":"An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques","volume":"11","author":"Feng","year":"2020","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.biomaterials.2021.121062_bib15","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.00823-14","article-title":"Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice","volume":"88","author":"Kim","year":"2014","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121062_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nri.2015.17","article-title":"Mucosal immunity to pathogenic intestinal bacteria","volume":"16","author":"Perez-Lopez","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic immunity and the microbiota","volume":"46","author":"Belkaid","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-010-0696-0","article-title":"Development of adenoviral vector-based mucosal vaccine against influenza","volume":"89","author":"Tutykhina","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"4 Suppl","key":"10.1016\/j.biomaterials.2021.121062_bib19","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121062_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/v11020154","article-title":"Preexisting virus-specific T lymphocytes-mediated enhancement of adenovirus infections to human blood CD14+ cells","volume":"11","author":"Feng","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.biomaterials.2021.121062_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","article-title":"Adenovirus sensing by the immune system","volume":"21","author":"Atasheva","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.biomaterials.2021.121062_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2019.01605","article-title":"Innovative mucosal vaccine formulations against influenza A virus infections","volume":"10","author":"Calzas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121062_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2019.00779","article-title":"Replicating adenovirus-SIV immunization of rhesus macaques induces mucosal dendritic cell activation and function leading to rectal immune responses","volume":"10","author":"Ko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121062_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biomaterials.2016.08.035","article-title":"Biomineralized vaccine nanohybrid for needle-free intranasal immunization","volume":"106","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121062_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1084\/jem.20131768","article-title":"Immunity induced by a broad class of inorganic crystalline materials is directly controlled by their chemistry","volume":"211","author":"Williams","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121062_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinf.2010.03.005","article-title":"Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys","volume":"60","author":"Sun","year":"2010","journal-title":"J. Infect."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121062_bib27","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.4049\/jimmunol.160.12.6101","article-title":"Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Gu\u00e9rin in IL-12-deficient mice","volume":"160","author":"Wakeham","year":"1998","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.121062_bib28","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/JVI.03247-12","article-title":"Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys","volume":"87","author":"Sun","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"30","key":"10.1016\/j.biomaterials.2021.121062_bib30","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1039\/C6NR03256G","article-title":"Recent advances in chitosan-based nanoparticulate pulmonary drug delivery","volume":"8","author":"Islam","year":"2016","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jviromet.2013.03.019","article-title":"Development of a new cell culture-based method and optimized protocol for the detection of enteric viruses","volume":"191","author":"Lee","year":"2013","journal-title":"J. Virol Methods"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/icb.2008.3","article-title":"The cell biology of cross-presentation and the role of dendritic cell subsets","volume":"86","author":"Lin","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"7340","key":"10.1016\/j.biomaterials.2021.121062_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature09863","article-title":"Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection","volume":"471","author":"Wakim","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2021.121062_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fimmu.2014.00140","article-title":"Antigen cross-presentation of immune complexes","volume":"5","author":"Platzer","year":"2014","journal-title":"Front. Immunol."},{"issue":"5824","key":"10.1016\/j.biomaterials.2021.121062_bib35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1137971","article-title":"Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation","volume":"316","author":"Burgdorf","year":"2007","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121062_bib36","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1182\/blood-2006-10-051375","article-title":"hDectin-1 is involved in uptake and cross-presentation of cellular antigens","volume":"111","author":"Weck","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121062_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jgm.895","article-title":"Specific and efficient targeting of adenovirus vectors to macrophages: application of a fusion protein between an adenovirus-binding fragment and avidin, linked to a biotinylated oligonucleotide","volume":"8","author":"Emile Gras","year":"2006","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/mt.2015.4","article-title":"Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression","volume":"23","author":"Curran","year":"2015","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121062_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41579-018-0036-x","article-title":"Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier","volume":"16","author":"Martens","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biomaterials.2021.121062_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biomaterials.2017.03.007","article-title":"Engineering intravaginal vaccines to overcome mucosal and epithelial barriers","volume":"128","author":"Ji","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121062_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type I interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2021.121062_bib42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12916-017-0911-8","article-title":"The public health value of vaccines beyond efficacy: methods, measures and outcomes","volume":"15","author":"Wilder-Smith","year":"2017","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2021.121062_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro3360","article-title":"Novel vaccine vectors for HIV-1","volume":"12","author":"Barouch","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"14","key":"10.1016\/j.biomaterials.2021.121062_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00542-20","article-title":"Lactoferrin-hexon interactions mediate CAR-independent adenovirus infection of human respiratory cells","volume":"94","author":"Persson","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.biomaterials.2021.121062_bib46","doi-asserted-by":"crossref","unstructured":"K.L. Emmer, H.C.J. Ertl, Chapter 24 - recombinant adenovirus vectors as mucosal vaccines, in: H. Kiyono, D.W. Pascual (Eds.), Mucosal Vaccines (second ed.), Academic Press2020, pp. 419-444.","DOI":"10.1016\/B978-0-12-811924-2.00024-9"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121062_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4155\/tde.14.89","article-title":"Nanocarriers: a versatile approach for mucosal vaccine delivery","volume":"6","author":"Mody","year":"2015","journal-title":"Ther. Deliv."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121062_bib48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2217\/nnm-2017-0015","article-title":"Recent developments in nanocarrier-aided mucosal vaccination","volume":"12","author":"Kammona","year":"2017","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1021\/mp200264m","article-title":"Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines","volume":"9","author":"Chua","year":"2012","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121062_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121062_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201813666160804121123","article-title":"Advances and potential applications of chitosan nanoparticles as a delivery carrier for the mucosal immunity of vaccine","volume":"14","author":"Li","year":"2017","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121062_bib52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121062_bib53","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.1301695","article-title":"Spectrum and mechanisms of inflammasome activation by chitosan","volume":"192","author":"Bueter","year":"2014","journal-title":"J. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.biomaterials.2021.121062_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0264-410X(02)00448-6","article-title":"Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design","volume":"21","author":"Herrera","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121062_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1462-5822.1999.00026.x","article-title":"Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules","volume":"1","author":"Ramachandra","year":"1999","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.biomaterials.2021.121062_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122100418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122100418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:06:03Z","timestamp":1758906363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122100418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":56,"alternative-id":["S014296122100418X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121062","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121062"}}